Gilpin Wealth Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$233 Buy
5
+4
+400% +$144 ﹤0.01% 881
2026
Q1
$25 Sell
1
-2
-67% -$47 ﹤0.01% 991
2025
Q4
$75 Buy
+3
New +$80 ﹤0.01% 885

Other funds holding ASTH

Gilpin Wealth Management's ASTH Position: Q2 2026 in Review

Gilpin Wealth Management increased its Astrana Health (ASTH) stake by 400% in Q2 2026, buying an estimated $144 and bringing the position to 5 shares worth $233. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Gilpin Wealth Management first reported a position in ASTH in Q4 2025 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Gilpin Wealth Management held 5 shares of Astrana Health worth $233 as of Q2 2026.
  • Gilpin Wealth Management bought 4 Astrana Health shares in Q2 2026, an estimated $144.
  • Astrana Health made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #881 holding.
  • Gilpin Wealth Management first reported a position in Astrana Health in Q4 2025 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.